Onco-Innovations Ltd. is a Canadian biotech company, which engages in cancer research and treatment, specializing in oncology. The company is headquartered in Calgary, Alberta. The company went IPO on 2024-11-27. The firm holds an exclusive worldwide license to patented technology that targets solid tumors. The firm is engaged in developing and commercializing treatments for various types of cancer. Its solution focuses on targeting cancer cells, effectively eliminating them and preventing their regrowth. Its licensed technology focuses on Polynucleotide Kinase 3'-Phosphatase (PNKP) inhibitors. Its SynoGraph platform merges genomic, proteomic, and multimodal datasets to uncover deep insights into disease mechanisms, potentially enabling more personalized and effective treatment strategies.
ONNVF stock price ended at $1.1 on 月曜日, after dropping 7.56%
On the latest trading day Dec 22, 2025, the stock price of ONNVF fell by 7.56%, dropping from $1.10 to $1.10. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $1.10 and a high of $1.10. On the latest trading day, the trading volume for ONNVF decreased by 3.2K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 800 shares were traded, with a market value of approximately --.